Ulcerative

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 21, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that it will host a live investor call and webcast…

Icanbelimod demonstrated sustained clinical remission, a regulatory relevant efficacy endpoint, through Week 48 in 80% of patients who achieved clinical remission at Week 12 of the…

Guselkumab (Tremfya) results in clinically meaningful improvements demonstrated across…

Elana Gotkine FRIDAY, March 17, 2023 (HealthDay News) -- In a clinical practice guideline issued by the American Gastroenterological Association and…

RVT-3101 demonstrated statistically significant and clinically meaningful efficacy at each dose testedAcross all patients treated with RVT-3101, the clinical remission and endoscopic…

– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at week 12 – AMT-101 was well-tolerated – Planned Phase 1b trial for the…

A poster presentation at the Advances in Inflammatory Bowel Diseases annual meeting revealed that more…

ORLANDO -- More than a third of patients with ulcerative colitis also experienced debilitating joint pain, which can wreak…

Induction treatment with upadacitinib (Rinvoq) provided rapid symptom relief from day 1 for…

Ulcerative colitis relapses in patients with moderate-to-severe disease were seen as early as 8 weeks among…